Author

Sérgio Serrano

Observed names: S Serrano, S Serrano Figueras, S. SERRANO, S. Serrano, Sergio Dr. Serrano, Sergio Serrano, Sergio Serrano Figueras, Sergio Serrano-Figueras, Serrano, Sergio Vicente

Observed institutions: Institució Catalana de Recerca i Estudis Avançats, Universitat Autònoma de Barcelona, Universitat Pompeu Fabra, Institut d'Investigació Biomédica de Bellvitge, Hospital Clínic de Barcelona, Institut Municipal d'Assistència Sanitària, Vall d'Hebron Hospital Universitari, Hospital Del Mar, Parc de Salut, Municipal Institute for Medical Research, Hospital Universitari Germans Trias i Pujol, Hospital del Mar Research Institute, Herbert Irving Comprehensive Cancer Center, Istituto Oncologico della Svizzera Italiana, Columbia University

ORCID: 0000-0003-1222-9016

Observed ORCID: 0000-0003-1222-9016

OpenAlex ID: A5023944964

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

2010 · Marta Salido, Cristina Baró, et al. · Blood · 191

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

2010 · Marta Salido, Lara Pijuan, et al. · Journal of Thoracic Oncology · 158

Gastrointestinal Involvement in Mantle Cell Lymphoma: A Prospective Clinic, Endoscopic, and Pathologic Study

2006 · Antonio Salar, Nuria Juanpere, et al. · The American Journal of Surgical Pathology · 137

Expression profiles associated with aggressive behavior in Merkel cell carcinoma

2006 · María-Teresa Fernández-Figueras, Lluís Puig, et al. · Modern Pathology · 88

PDF

FGFR3 mutations in prostate cancer: association with low-grade tumors

2009 · Silvia Hernández, Silvia de Muga, et al. · Modern Pathology · 75

PDF

Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides

2009 · Rocío Salgado, Octavio Servitje, et al. · Journal of Investigative Dermatology · 73

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas

2010 · Silvia de Muga, Silvia Hernández, et al. · Modern Pathology · 71

WHO ‐histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes

2014 · Alberto Alvarez‐Larrán, Agueda Ancochea, et al. · British Journal of Haematology · 67

Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

2015 · Alba Font‐Tello, Núria Juanpere, et al. · The Prostate · 65

Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer

2012 · Nuria Juanpere, Laia Agell, et al. · Human Pathology · 64

Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study

2010 · Federico Rojo, Elías Gracias, et al. · Clinical Cancer Research · 64

PDF

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)

2015 · David Casadevall, Javier Gimeno, et al. · Oncotarget · 62

PDF

A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer

2012 · Laia Agell, Silvia Hernández, et al. · American Journal Of Pathology · 57

PDF

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

2010 · Laia Agell, Silvia Hernández, et al. · Modern Pathology · 52

PDF

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

2010 · Beatriz Sánchez-Espiridión, Carlos Montalbán, et al. · Blood · 50

The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma

2006 · Cristina Corzo, Josep M. Corominas, et al. · Cancer Genetics and Cytogenetics · 50

Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry

2013 · Blanca Espinet, Ana Ferrer, et al. · Clinical Cancer Research · 48

Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype

2015 · Inmaculada Ribera-Cortada, Daniel Martinez, et al. · Modern Pathology · 44

Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

2008 · Itziar Salaverria, Blanca Espinet, et al. · Genes Chromosomes and Cancer · 31

Effects of Linoleic Acid Supplements on Atopic Dermatitis

1997 · Ana Giménez-Arnau, Carlos Barranco, et al. · Advances in experimental medicine and biology · 30

ROS1 copy number alterations are frequent in non-small cell lung cancer

2016 · Sergi Clavé, Javier Gimeno, et al. · Oncotarget · 27

PDF

Molecular Characteristics of Mantle Cell Lymphoma Presenting With Clonal Plasma Cell Component

2011 · Carlo Visco, Sylvia Hoeller, et al. · The American Journal of Surgical Pathology · 23

Persistent Residual Disease in t(11;18)(q21;q21) Positive Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Chemotherapy or Rituximab

2005 · Antonio Salar, Beatriz Bellosillo, et al. · Journal of Clinical Oncology · 23

PDF

ConcurrentTMPRSS2-ERGandSLC45A3-ERGrearrangements plusPTENloss are not found in low grade prostate cancer and define an aggressive tumor subset

2016 · Silvia Hernández, Alba Font-Tello, et al. · The Prostate · 18

Value of p16INK4a in the diagnosis of low‐grade urothelial carcinoma of the urinary bladder in urinary cytology

2012 · Francesc Alameda, Nuria Juanpere, et al. · Cancer Cytopathology · 15

Works count: 68

Citation count: 1,699

H-index: 23

I10-index: 32